Aragen Signs Collaboration Agreement with Azurity Pharmaceuticals to Set up Dedicated Formulations Development Center

Aragen Life Sciences Private Limited (“Aragen”), a global contract research, development, and manufacturing organization (CRDMO) announces a collaboration with Azurity Pharmaceuticals Inc, a US-based pharmaceutical company focused on developing innovative dose-forms and formulations of products to serve the needs of overlooked patients. The agreement is for a dedicated pharmaceuticals formulations development center at Aragen’s Hyderabad campus. The dedicated center will support the development of multiple products across a wide range of therapeutic areas. 

Aragen Signs Collaboration Agreement with Azurity Pharmaceuticals to Set up Dedicated Formulations Development Center